Neuronetics, Inc.
STIM
$4.32
-$0.31-6.70%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.53M | 16.45M | 17.42M | 20.31M | 17.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.53M | 16.45M | 17.42M | 20.31M | 17.88M |
| Cost of Revenue | 4.53M | 4.27M | 4.33M | 2.64M | 6.12M |
| Gross Profit | 14.00M | 12.18M | 13.09M | 17.67M | 11.76M |
| SG&A Expenses | 19.31M | 18.45M | 17.60M | 17.89M | 18.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.26M | 24.96M | 24.28M | 22.74M | 26.76M |
| Operating Income | -7.73M | -8.51M | -6.86M | -2.43M | -8.87M |
| Income Before Tax | -13.34M | -9.83M | -7.87M | -5.38M | -9.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.34M | -9.83M | -7.87M | -5.38M | -9.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.34M | -9.83M | -7.87M | -5.38M | -9.39M |
| EBIT | -7.73M | -8.51M | -6.86M | -2.43M | -8.87M |
| EBITDA | -7.17M | -8.00M | -6.30M | -2.01M | -8.33M |
| EPS Basic | -0.44 | -0.33 | -0.27 | -0.19 | -0.33 |
| Normalized Basic EPS | -0.18 | -0.20 | -0.17 | -0.07 | -0.20 |
| EPS Diluted | -0.44 | -0.33 | -0.27 | -0.19 | -0.33 |
| Normalized Diluted EPS | -0.18 | -0.20 | -0.17 | -0.07 | -0.20 |
| Average Basic Shares Outstanding | 30.27M | 30.05M | 29.47M | 29.05M | 28.88M |
| Average Diluted Shares Outstanding | 30.27M | 30.05M | 29.47M | 29.05M | 28.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
